You are here: Industry Insights > develop

News List

Innovent Biologics Announces a New Placement Raised HK$2,351.33 Million En-CPhI.CN
October 08, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology ...
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer En-CPhI.CN
October 08, 2019
Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral ...
ADCendo secures loan to advance ADCs for cancer treatment pharmaceutical-technology
September 03, 2019
ADCendo has secured a loan amount to advance its novel antibody-drug conjugates (ADCs) that are being developed to treat cancers.
Vaxxilon receives grant to develop new prophylactic vaccine pharmaceutical-technology
August 21, 2019
Switzerland-based synthetic vaccines firm Vaxxilon has received a funding grant from CARB-X to support the development of a prophylactic, multivalent vaccine against carbapenem-resistant Klebsiella pneumoniae (crKP).
Researchers develop compound to reduce injury due to heart attacks pharmaceutical-technology
August 20, 2019
Researchers from Virginia Tech University (VT) have developed a variant of the compound alphaCT1, which can improve heart attack recovery if administered during, or soon after, a heart attack.
Progress made in developing first Chlamydia vaccine pharmaceutical-technology
August 14, 2019
Researchers from Statens Serum Institut (SSI), Denmark, and Imperial College London have published promising results from the first clinical trial of a vaccine for Chlamydia, the most common sexually transmitted disease.
Sanofi to develop Verastem’s Copiktra in certain regions pharmaceutical-technology
July 29, 2019
Sanofi has signed a licensing agreement to develop and commercialise Verastem Oncology’s Copiktra (duvelisib) in Russia and CIS, Turkey, the Middle East and Africa.
AUM Biosciences to develop Inflection’s cancer therapy pharmaceutical-technology
July 19, 2019
Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of PIM/PI3K/mTOR inhibitor molecules.
Researchers develop ‘Trojan horse’ chemo drug delivery system pharmaceutical-technology
July 19, 2019
Northwestern University researchers have developed a drug delivery system that can disguise chemotherapy drugs as fat, meaning that tumours readily consume them, the drugs are then activated to suppress tumour growth and eventually the tumour dies.
Researchers develop genomic barcode to track immune cells pharmaceutical-technology
July 18, 2019
A Garvan Institute of Medical Research team in Australia has created a genomic barcode to identify immune cells that recognise and act against cancer from within a patient’s immune system.

Previous page 1 2 Next page